EP
ARNA

Eversept Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Eversept Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,900
Closed -$826K – 77
2018
Q1 		$826K Buy
+20,900
New +$813K 0.38% 40

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Eversept Partners's ARNA Position: Q3 2019 in Review

Eversept Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 73,501 shares — an estimated $4.31M sold.

Eversept Partners first reported a position in ARNA in Q1 2018 and held it in 6 quarters. The position peaked at $8.72M in Q1 2018. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

  • Eversept Partners reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Eversept Partners sold 73,501 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $4.31M.
  • Eversept Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 6 quarters.
  • Eversept Partners's Arena Pharmaceuticals Inc position peaked at $8.72M in Q1 2018.
  • 230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Eversept Partners's 13F filing for Q3 2019, filed 13 Nov 2019.